eSource Expert Meeting Postponed

Considering the approach many organisations have taken to protect employees from the risk of exposure to the coronavirus (COVID-19), Foundry Health has decided to postpone this meeting. Depending on how the situation develops, we hope to reschedule for the Fall of 2020.

eSource Expert Meeting, Antwerp, May 2020

We’d like to let you know about a two-day eSource expert meeting to be held in the historical city of Antwerp, Belgium, May 2020.

Frontage Clinical Adopts ClinSpark

The Foundry Health team is excited to share another ClinSpark success story. Frontage Clinical Services Inc. (Frontage Clinical), a full service contract research organization, has recently announced its successful implementation of ClinSpark, the eSource platform for Phase I clinical trial automation.

Worldwide Clinical Trials Adopts ClinSpark

The Foundry Health team is excited to share another ClinSpark success story. Worldwide Clinical Trials (Worldwide), an award-winning, full-service, midsize, global contract research organization has recently announced its successful implementation of ClinSpark, the eSource platform for Phase I clinical trial automation.

ClinSpark version 1.4.2 Released

The Foundry Health team is excited to announce the latest release of its eSource software platform for Phase I automation. This version contains enhancements over version 1.4.1 released earlier this year.

ClinSpark version 1.4.1 Released

The Foundry Health team is excited to announce the latest release of its eSource software platform for Phase I automation. Version 1.4.1 contains enhancements over version 1.4.0 released earlier this year, and significantly enhances the recruitment module.

QPS Adopts ClinSpark

The Foundry Health team is excited to share another ClinSpark success story. QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, recently announced its successful implementation of ClinSpark, an eSource technology platform for Phase I automation, to support double digit growth in Phase I clinical trials.

History